Bristol-Myers Squibb Company
Biaryl kinase inhibitors
Last updated:
Abstract:
The present disclosure is generally directed to compounds which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds, and methods for inhibiting AAK1.
Status:
Grant
Type:
Utility
Filling date:
18 Jun 2019
Issue date:
28 Jul 2020